Relay Therapeutics RLAY Cash Flow Statement (2019-2026)

NASDAQ RLAY
$18.78 +0.33 (+1.79%)
As of: Oct 21, 2026 · 10:13 AM EDT
Reported Financials

Relay Therapeutics Quarterly Cash Flow Statement

Periods 29 quarters
Latest Jun 2026

Relay Therapeutics reported cash from operations of -$54.11M and free cash flow of -$54.11M for the quarter ended Jun 2026, up 2.1% year over year. This cash flow statement covers 29 quarters of results from Jun 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-60.83M-67.46M-62.05M-76.79M-84.17M-67.50M-94.24M-98.51M-65.73M-83.50M-81.39M-92.21M-88.11M-76.00M-77.07M-70.38M-74.15M-54.89M-73.29M-83.71M
Depreciation and DepletionDep. & Depletion
1.01M1.03M0.98M0.96M1.03M1.17M1.20M1.33M1.36M1.38M1.40M1.37M1.37M1.33M1.21M1.00M0.75M0.60M0.50M0.36M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
1.01M1.03M0.98M0.96M1.03M1.17M1.20M1.33M1.36M1.38M1.40M1.37M1.37M1.33M1.21M1.00M0.75M0.60M0.50M0.36M
Share-based CompensationStock Comp.
12.42M10.22M13.46M15.15M13.72M13.82M21.52M23.41M21.84M19.27M27.19M26.83M22.48M17.64M19.33M14.50M15.53M13.07M10.54M9.18M
Gains from Sales and DivestituresGains Divest
-0.35M-0.04M
Other non-cash itemsOther Non-Cash
2.00M0.84M-4.60M0.20M3.26M-10.54M-1.00M-2.15M-1.20M-2.07M-1.83M-11.37M
Change in Working Capital
Change in ReceivablesChange Receivables
0.53M-0.40M-0.13M0.02M-0.05M0.07M-0.02M-0.21M0.13M-0.21M
Change in Account PayablesChange Payables
-0.64M2.43M-1.22M-3.39M4.63M1.97M1.40M2.80M-1.22M-5.37M0.10M3.21M-4.30M
Change in Accured ExpensesChange Accured Exp.
4.82M7.92M3.05M6.49M17.89M-16.14M5.60M-1.51M-19.52M5.84M7.65M8.77M1.14M-7.29M-3.45M-0.95M-0.51M-6.53M3.67M20.52M
Change in Other Operating AssetsOther Assets Change
12.11M-4.47M-0.57M0.09M15.64M-13.02M-0.02M-2.66M8.27M-0.96M0.48M-4.64M9.67M-0.15M3.93M-5.69M3.97M-3.82M-7.36M0.75M
Change in Other Operating LiabilitiesOther Liabilities Change
-0.08M-0.08M-0.08M10.76M0.01M-24.97M0.46M-0.89M0.59M8.31M-7.99M-1.07M0.47M-0.62M0.38M0.41M
Other Working Capital ChangesOther WC Changes
-0.06M-0.29M-0.14M-0.09M-6.77M-1.14M0.42M4.50M0.35M0.33M0.28M0.28M0.28M-5.57M0.51M0.51M0.51M0.51M
Cash from OperationsCash from Ops.
-53.20M-39.71M-49.17M-57.09M-66.15M-57.08M-67.13M-68.60M-75.40M-89.19M-50.32M-65.83M-75.08M-57.87M-73.21M-55.26M-62.12M-44.87M-51.11M-54.11M
Investing Activities
Capital ExpendituresCapex
1.74M0.88M2.79M1.86M2.10M2.32M1.92M1.50M0.59M0.12M1.78M0.01M0.23M0.38M0.03M0.00M0.00M
Change in Property, Plant and EquipmentChange in PP&E
-1.74M-0.88M-2.79M-1.86M-2.10M-2.32M-1.92M-1.50M-0.59M-0.12M-1.78M-0.01M-0.23M-0.38M-0.03M0.00M0.00M
Acquisitions
0.08M0.08M
Net of Acquisitions & DivestmentsNet Acquisitions
-0.08M-0.08M
Purchase of InvestmentsInvestments Purchased
7.39M327.03M127.69M24.26M55.83M327.64M97.82M66.16M84.75M136.82M190.78M119.63M265.14M75.08M21.97M8.93M58.08M34.00M50.90M471.33M
Sale and Maturity of InvestmentsInvestments Sold
30.00M35.25M18.10M69.50M85.12M183.02M175.04M118.94M156.71M196.61M203.10M165.20M139.20M104.07M64.82M84.10M97.80M69.46M83.80M118.30M
Cash from Investing ActivitiesCash from Investing
20.79M-292.75M-112.38M43.39M27.19M-146.94M75.31M51.28M71.37M59.68M10.53M45.55M-126.16M29.00M42.47M75.15M39.73M35.46M32.90M-353.03M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.90M1.80M0.88M2.00M1.12M1.17M1.30M2.08M-1.53M2.63M30.99M0.41M0.73M-2.33M0.02M1.69M
Net Shares Issued and RepurchasedNet Shares Issued
0.90M1.80M0.88M2.00M1.12M1.17M1.30M2.08M-1.53M2.63M30.99M0.41M0.73M-2.33M0.02M1.69M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
Net Equity Issued and RepurchasedNet Equity Issued
0.90M1.80M0.88M2.00M1.12M1.17M1.30M2.08M-1.53M2.63M30.99M0.41M0.73M-2.33M0.02M1.69M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
0.90M384.01M0.88M2.00M285.87M1.17M1.30M2.08M9.46M21.92M48.92M1.54M218.89M0.80M0.02M0.93M138.78M323.74M
Additional items
Change in Cash
-31.51M51.56M-160.67M-11.71M246.91M-202.85M9.48M-15.24M5.43M-7.59M9.13M-18.74M17.64M-28.07M-30.75M20.54M-22.38M-8.47M120.57M-83.40M
Ending Cash Balance
282.70M154.37M146.44M126.41M85.35M
Free Cash FlowFCF
-54.94M-40.59M-51.97M-58.95M-68.24M-59.40M-69.05M-70.10M-75.99M-89.31M-52.10M-65.84M-75.31M-57.87M-73.59M-55.29M-62.12M-44.87M-51.11M-54.11M
Net Cash FlowNCF
-31.51M51.56M-160.67M-11.71M246.91M-202.85M9.48M-15.24M5.43M-7.59M9.13M-18.74M17.64M-28.07M-30.75M19.89M-22.38M-8.47M120.57M-83.40M

Relay Therapeutics Cash Flow Statement API

Pull Relay Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=RLAY&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY